Company Number: 13122311

Analysis Date: 2025-07-20 11:51 UTC

Financial Health Assessment of INGE THERON & ASSOCIATES LIMITED

---

1. Financial Health Score: B

Explanation:
The company demonstrates strong liquidity and positive net current assets, reflecting a generally healthy short-term financial position. However, there is a noticeable decline in net assets and shareholders’ funds in 2023 compared to previous years, signaling potential early symptoms of financial strain. The micro-entity size and limited fixed assets further contextualize the scale and scope of operations.

---

2. Key Vital Signs

Metric	2023 Value (£)	Interpretation
Fixed Assets	772	Very low investment in long-term assets, typical for a micro company. No fixed asset base to rely on for collateral or long-term operations.
Current Assets	419,517	Healthy cash and receivables pool, indicating good liquidity.
Current Liabilities	223,127	Substantial short-term obligations, but manageable given current assets.
Net Current Assets	196,390	Positive working capital, a sign of healthy short-term operational funding.
Total Assets Less Current Liabilities	197,162	Indicates overall assets after short-term obligations, decreased from prior years.
Shareholders’ Funds	197,162	Equity capital backing the company, down from £293,359 in 2022, indicating some erosion of retained earnings or capital.
Average Employees	1	Minimal staffing, consistent with micro-entity status.

Trends & Observations:

• Net assets and shareholders’ funds have declined by approximately 33% from 2022 to 2023.
• Current assets increased, but current liabilities grew at a faster rate, reducing net current assets compared to 2022.
• Fixed assets dropped sharply after a large figure in 2021, now negligible, indicating asset disposals or reclassification.
• No audit required due to micro-entity exemption, which may limit external financial scrutiny.

---

3. Diagnosis

The financial "vital signs" suggest INGE THERON & ASSOCIATES LIMITED is currently in a stable but cautious state of health. The company exhibits a "healthy cash flow" position with strong current assets relative to liabilities, which is critical for meeting short-term obligations and operational needs.

However, the "symptoms of distress" appear in the significant reduction of net assets and shareholders’ funds from 2022 to 2023. This could point to retained losses, increased expenses, or one-off events impacting equity. The lack of fixed assets may indicate a service-based business model with limited capital investment, which is typical in specialised design activities (SIC 74100).

Overall, the company is not in immediate danger but shows early signs that require monitoring. The limited staff count and micro-entity status suggest a lean operation, which may be vulnerable to market fluctuations or cash flow shocks.

---

4. Recommendations

• Investigate Equity Decline: Conduct a deeper analysis of profit and loss components to understand the cause of reduced shareholders’ funds. Identify if the decline is due to operational losses, increased liabilities, or extraordinary expenses.
• Strengthen Working Capital Management: Although current assets cover liabilities, the rising current liabilities warrant careful cash flow forecasting to avoid liquidity crunches.
• Asset Strategy Review: Consider whether reinvesting in fixed assets or intangible assets (e.g., software, design tools) could improve productive capacity or competitive positioning.
• Financial Reporting and Controls: Even though audit exemption applies, periodic internal reviews or voluntary audits could help detect early financial issues and improve stakeholder confidence.
• Succession and Growth Planning: With only one employee and a small equity base, develop plans for scaling operations, diversifying client base, or enhancing service offerings to strengthen financial resilience.
• Director Oversight: The recent appointment of a new director and secretary consolidating roles suggests streamlined governance; maintain robust oversight to ensure financial discipline.

---